$QNTBullishMed

Quantinuum Announces Pricing of Upsized Initial Public Offering

Quantinuum priced an upsized IPO of 28,000,000 Class A shares at $60.00 each, with an underwriters’ 30-day option to buy up to 4,200,000 additional shares for over-allotments. Shares are expected to start trading on Nasdaq June 4, 2026 under QNT, and close June 5. J.P. Morgan and Morgan Stanley are joint lead managers.

Med
Bullish
Expected to begin trading on Nasdaq Global Market today (June 4, 2026).
Risk-on for speculative growth/quantum, but IPO mechanics can create short-term selling/volatility.

IPO pricing and share count define near-term supply/demand and first-trading reference levels for QNT.

Quantinuum priced an upsized IPO at $60/share with 28M shares plus an over-allotment option, setting the Nasdaq debut terms.

Likely initial volatility around the $60 IPO price as investors digest the upsized deal and potential over-allotment.

Background

Quantinuum is a quantum computing company; the release announces the pricing details and timing for its upsized IPO.

Why it matters

The priced share count ($60/share; 28M shares plus up to 4.2M over-allotment) and Nasdaq start date are the key tradable inputs for QNT around the debut window.

Market relevance

This is a primary-market catalyst for QNT with a defined debut date and priced terms, making it relevant for immediate trading and positioning.

Market effects

A successful upsized IPO can improve sentiment toward quantum/early-stage tech funding, but it is company-specific rather than a sector reset.

Minimal direct regional impact; deal is US-listed and investor-driven.

Limited global read-through beyond investor appetite for quantum computing listings.

Alternative perspectives

Upsized IPOs can increase near-term float and unlock risk, leading to post-open selling even if pricing is strong.

First-day performance will depend on IPO allocation/lockup expectations and broader market risk appetite at the open, not just the $60 price.

Key entities

  • Quantinuum Inc.

    Subject of the IPO pricing announcement; Class A shares priced at $60 and expected to start trading on Nasdaq under QNT.

  • Securities and Exchange Commission (SEC)

    Registration statement declared effective on June 3, 2026, enabling the IPO pricing and launch.

Related articles

$UALLow

13 Top Press Releases from May

PR Newswire’s June 5 recap highlights May press releases including United’s offer of price-capped one-way tickets for Spirit customers after flight cancellations, and eBay’s rejection of an unsolicited GameStop proposal. It also notes Lilly’s Phase 3 retatrutide obesity results, a telecom satellite joint venture, and other corporate updates, plus May holiday and earnings-related trends.

$QNTMed

Benzinga

Quantinuum Inc (NASDAQ: QNT) began trading on its first Nasdaq session at $68 per share, up 13.3% from its $60 IPO price on 28 million shares, according to Benzinga. Pre-market indications ranged from about $61.50 to a peak near $78 before stabilizing at $68 for the opening print, reflecting strong institutional and retail demand.

$QNTMed

Quantinuum Sends Qnt Stock Toward Nasdaq Debut and $14.3 Billion

Quantinuum, a Honeywell-backed quantum computing company, is preparing for a Nasdaq debut and is seeking a valuation of up to $14.3 billion, according to the article. The planned offering could be among the largest in the sector, and traders may use its pricing as a reference point for other quantum stocks ahead of listing.

$QNTMed

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.